Literature DB >> 12944166

Quercetin sensitizes cells in a tumour-like low pH environment to hyperthermia.

P R Wachsberger1, R Burd, A Bhala, S B Bobyock, M L Wahl, C S Owen, S B Rifat, D B Leeper.   

Abstract

Quercetin has been shown to act as a hyperthermia sensitizer by inhibiting the synthesis of heat shock protein 70 (HSP70) in a variety of tumour cell lines. It is most effective under conditions of low pH. This study was designed to test the hypothesis that quercetin suppresses thermotolerance development in cells adapted to growth at low pH and renders them as responsive as acutely acidified cells to hyperthermia-induced cytotoxicity. Chinese hamster ovarian carcinoma cells (OvCa) were exposed to 42 degrees C hyperthermia and/or quercetin (50-200 mm) at their growth pH of either 7.3 or 6.7 or after acute acidification from 7.3 to 6.7. Thermotolerance development was measured by colony survival. HSP70 synthesis and total protein synthesis were measured by radioactive precursor pulse labelling techniques. Quercetin, in a concentration-dependent manner, reduced the rate of total protein synthesis and increased cytotoxicity equally after acute acidification to pH 6.7 or growth at pH 6.7 at 37 degrees C, and to a greater extent than it did in cells at pH 7.3. At 42 degrees C, 100 mm quercetin inhibited total protein synthesis, HSP70 synthesis and thermotolerance development to a similar extent in cells grown at pH 6.7 or acutely acidified to pH 6.7. In contrast, quercetin reduced but did not completely inhibit HSP70 synthesis and thermotolerance development in cells grown and heated at pH 7.3. These results support the hypothesis that quercetin can specifically reduce thermotolerance development in tumour cells adapted to growth at pHe 6.7 so that they respond similarly to acutely acidified cells. Since many tumours are adapted to growth at low pH and may resist a wide variety of therapeutic modalities, inhibition of thermotolerance expression by quercetin may not only enhance the response to hyperthermia but the response to commonly used therapies such as chemotherapy and radiation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12944166     DOI: 10.1080/0265673031000078697

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  4 in total

Review 1.  Chaperone proteins and brain tumors: potential targets and possible therapeutics.

Authors:  Michael W Graner; Darell D Bigner
Journal:  Neuro Oncol       Date:  2005-07       Impact factor: 12.300

Review 2.  Emerging Applications of Ultrasound-Contrast Agents in Radiation Therapy.

Authors:  Quezia Lacerda; Mohamed Tantawi; Dennis B Leeper; Margaret A Wheatley; John R Eisenbrey
Journal:  Ultrasound Med Biol       Date:  2021-02-27       Impact factor: 3.694

3.  Response: Commentary: The Impact of the Time Interval Between Radiation and Hyperthermia on Clinical Outcome in Patients With Locally Advanced Cervical Cancer.

Authors:  Johannes Crezee; Arlene L Oei; Nicolaas A P Franken; Lukas J A Stalpers; H Petra Kok
Journal:  Front Oncol       Date:  2020-04-15       Impact factor: 6.244

4.  Blockade of PI3K/AKT pathway enhances sensitivity of Raji cells to chemotherapy through down-regulation of HSP70.

Authors:  Xiaosheng Fang; Yujie Jiang; Lili Feng; Haiping Chen; Changqing Zhen; Mei Ding; Xin Wang
Journal:  Cancer Cell Int       Date:  2013-05-24       Impact factor: 5.722

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.